What does this research mean for the field?

The Revised International Prognostic Scoring System (IPSS-R) predicts overall survival and leukemia-free survival in myelodysplastic syndromes significantly better than the original IPSS and the WHO Prognostic Scoring System. Novelty: ClaimNovelty.CONFIRMATORY. Consensus alignment: ConsensusAlignment.SUPPORTS_CONSENSUS.

June 25, 2013Journal of Clinical OncologyOpen Access

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

View Full Paper

Ask AI

Bookmark

Authors

MVMaria Teresa VosoUniversity of Rome Tor Vergata SFSusanna FenuUniversity of Rome Tor Vergata RLRoberto LatagliataAzienda Sanitaria Locale Viterbo

Discussion

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Voso et al. (2013) studied this question.

synapsesocial.com/papers/6a0ce1e832b1e5fd57fc09c6 https://doi.org/10.1200/jco.2012.48.0764

View Full Paper

Ask AI

Bookmark

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Discussion

Member takes

Implication

Key Points

Cite This Study

Revised International Prognostic Scoring System (IPSS) Predicts Survival and Leukemic Evolution of Myelodysplastic Syndromes Significantly Better Than IPSS and WHO Prognostic Scoring System: Validation by the Gruppo Romano Mielodisplasie Italian Regional Database

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider